Current Neuro-Oncology
Volume
27 Number 13
10 May 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 13, 10 May
Dela
Cruz FS, Fox E, DuBois SG, Friedman GK, Croop JM, Kim A,
Morgenstern DA, Balis FM, Macy ME, Pressey JG, Watt T, Krystal JI,
Vo KT, Mody R, Laetsch TW, Weigel BJ, O'Hara K, He CS, Aluri J,
Okpara CE, Glade Bender JL.
A
Phase 1/2 Study of Lenvatinib in Combination With Everolimus in
Recurrent and Refractory Pediatric and Young Adult Solid Tumors.
Pediatr
Blood Cancer.
2025 May 1:e31692. doi:
10.1002/pbc.31692. PMID:
40313040. Interventional study. ˍ
Mansoorian
S, Schmidt M, Weissmann T, Delev D, Heiland DH, Coras R,
Stritzelberger J, Saake M, Höfler D, Schubert P, Schmitter C,
Lettmaier S, Filimonova I, Frey B, Gaipl US, Distel LV, Semrau S,
Bert C, Eze C, Schönecker S, Belka C, Blümcke I, Uder M,
Schnell O, Dörfler A, Fietkau R, Putz F.
Reirradiation
for recurrent glioblastoma: the significance of the residual tumor
volume.
J
Neurooncol.
2025 May 1. doi:
10.1007/s11060-025-05042-9. PMID:
40310485. Observational study. ˍ
Zhang HW, Deng HZ, Feng YN, Tang XM, Su RR, Ouyang Y, Lin F, Wang
YL, Lei Y, Huang B.
Evaluating the
efficacy of advanced imaging techniques in differentiating
histological and molecular glioblastomas from adult diffuse
gliomas: PWI, DWI, and MRS.
Acta
Radiol. 2025 May 1:2841851251333328. doi:
10.1177/02841851251333328. PMID:
40313055.
Observational study˰ ˍ
Zhang J, Shen H, Yang Y, Mei Q, Liu J, Liu A.
The
role of chemotherapy in patients with gliomatosis cerebri: a
population-based study.
Neurosurg
Rev. 2025 May 2;48(1):399. doi:
10.1007/s10143-025-03552-8. PMID:
40314840.
Observational study˰ ˍ
Xiao Y, Nie Z, Huang J, Zhao J, Dong C, Zou Y, Li Z, Yan B, Hu Y,
Yang F, Lee JW, Lin AP, Tobochnik S, Zhou M, Lei Z.
Risk
Factors and Prognostic Implications of Tumor-Related Epilepsy in
Diffuse Glioma Patients: A Real-World Multicenter Study.
Brain
Behav. 2025 May 5;15(5):e70510. doi:
10.1002/brb3.70510. PMID:
40320911.
Observational study. ˍ
Moon
HH, Wongsawaeng Wave D, Park JE, Park SY, Baek S, Kim YH, Song SW,
Hong CK, Kim JH, Lee MH, Park YW, Ahn SS, Pollock JM, Barajas RF
Jr, Kim HS.
Maximum
Resection of Noncontrast-enhanced Tumor at MRI Is a Favorable
Prognostic Factor in IDH Wild-Type Glioblastoma.
Radiology.
2025 May 6;315(2):e241393.
doi:
10.1148/radiol.241393. PMID:
40326876. Observational study. ˍ
de la Fuente Villaverde I, Caso González A, Carbajales
Álvarez M, Martínez Torrón A, Fernández
Lastras S, García Llano JL, Lozano Blázquez A.
Vemurafenib for the treatment of BRAF
V600 mutated glioblastoma: A case report.
Farm
Hosp. 2025 May 7:S1130-6343(25)00038-8. doi:
10.1016/j.farma.2025.03.013. PMID:
40340151. Case report. ˍ
França Velo A, Giantini Larsen A, Humm JL, Zanzonico P,
Haque S, Souweidane M, Pandit-Taskar N.
Determination
of the Intralesional Distribution of Theranostic 124I-Omburtamab
Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic
Pontine Glioma.
J
Nucl Med. 2025 May 8:jnumed.124.267995. doi:
10.2967/jnumed.124.267995. PMID:
40306974.
Interventional study˰
ˍ
Laviv Y, Kasper EM.
Butterfly
glioblastoma: trends in therapeutic modalities, extent of
resection and survival in the temozolomide era. a SEER-based
study.
Neurosurg
Rev. 2025 May 8;48(1):406. doi:
10.1007/s10143-025-03558-2. PMID:
40338381.
Observational study. ˍ
Parvathy N, Bhardwaj N, Srinivasan R, Gupta N, Gupta P, Rohilla M,
Kundu R, Dey P, Gupta K, Kakkar N, Trehan A, Singh P, Madan R,
Salunke P.
The crucial role of
cerebrospinal fluid cytology in the diagnosis and prognosis of
medulloblastoma at M1 stage.
Clin
Neuropathol. 2025 May 8. doi:
10.5414/NP301656. PMID:
40338110.
Observational study˰ ˍ